Comment on

• The impact of three influenza epidemics on primary care in England and Wales.

  Fleming DM. Fleming DM. Pharmacoeconomics. 1996;9 Suppl 3:38-45; discussion 50-3. doi: 10.2165/00019053-199600093-00010. Pharmacoeconomics. 1996. PMID: 10160485
• Evaluating the impact of influenza vaccination. A North American perspective.

  Fedson DS. Fedson DS. Pharmacoeconomics. 1996;9 Suppl 3:54-61. doi: 10.2165/00019053-199600093-00013. Pharmacoeconomics. 1996. PMID: 10160488 Review.
• French economic evaluations of influenza and influenza vaccination.

  Levy E. Levy E. Pharmacoeconomics. 1996;9 Suppl 3:62-6. doi: 10.2165/00019053-199600093-00014. Pharmacoeconomics. 1996. PMID: 10160489
• Economic evaluation of influenza vaccination and economic modelling. Can results be pooled?

  Jefferson T, Demicheli V. Jefferson T, et al. Pharmacoeconomics. 1996;9 Suppl 3:67-72. doi: 10.2165/00019053-199600093-00015. Pharmacoeconomics. 1996. PMID: 10160490